PMID: 15218393Jun 26, 2004Paper

Crosslink breakers: a new approach to cardiovascular therapy

Current Opinion in Cardiology
Dinko SusicEdward D Frohlich

Abstract

Advanced glycation end-products accumulate on body proteins with aging, and their formation is greatly enhanced with rising plasma glucose level. Advanced glycation end-products bond together and, consequently, increase protein crosslinking. In the circulatory system, increased collagen crosslinking caused by advanced glycation end-products increases cardiovascular stiffness as well as the risk for cardiovascular morbidity and mortality. A breaker of advanced glycation end-products-related crosslinks, ALT-711, has been recently discovered. This review summarizes the latest evidence that breaking collagen crosslinks may be an efficient new therapeutic approach to the adverse cardiovascular and renal consequences of aging and diabetes. The results of recent studies clearly demonstrated that ALT-711, a breaker of advanced glycation end-products-related protein crosslinks, ameliorated the adverse cardiovascular and renal changes associated with aging, diabetes, and hypertension. In diabetic animals, ALT-711 improved left ventricular function, decreased ventricular collagen content and improved its solubility, reduced aortic stiffness, ameliorated diabetic nephrosclerosis, and improved renal function. In older spontaneously hyperten...Continue Reading

References

Nov 21, 1992·Annals of the New York Academy of Sciences·A T Lee, A Cerami
Jan 1, 1992·Advances in Pharmacology·R Bucala, A Cerami
Jul 1, 1995·Hypertension·M O'Rourke
Mar 1, 1993·American Journal of Hypertension·M E Safar
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y M LiH Vlassara
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·B CormanB I Levy
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·B H WolffenbuttelB I Lévy
Mar 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·M AsifT J Regan
Aug 5, 2000·Clinics in Geriatric Medicine·D W Kitzman
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·P V VaitkeviciusE G Lakatta
Jun 29, 2002·Circulation Research·Jun ChenMichael S Goligorsky
Mar 6, 2003·Cardiovascular Research·Santhosh K G KoshyHimanshu H Shukla
Apr 19, 2003·Circulation Research·David A Kass
Jul 4, 2003·American Journal of Physiology. Cell Physiology·Xueying Liu, Zoltán Spolarics
Oct 22, 2003·Archives of Biochemistry and Biophysics·George JerumsMark Cooper
Oct 22, 2003·Archives of Biochemistry and Biophysics·Sara VasanHank Founds

❮ Previous
Next ❯

Citations

Mar 23, 2005·Current Opinion in Pharmacology·Burton E Sobel, David J Schneider
May 7, 2009·Rejuvenation Research·Johan Svantesson Sjöberg, Sven Bulterijs
May 2, 2008·Journal of the American Society of Nephrology : JASN·Kasper RossingUNKNOWN PREDICTIONS Network
Apr 16, 2010·Canadian Journal of Physiology and Pharmacology·Kaushik M DesaiLingyun Wu
Aug 28, 2015·Journal of the American Society of Nephrology : JASN·Andréa E M StinghenAgnès Boullier
May 12, 2009·The Medical Clinics of North America·Michel E Safar
May 12, 2009·The Medical Clinics of North America·Anil Verma, Scott D Solomon
Mar 4, 2008·Heart Failure Clinics·Dinko Susic, Edward D Frohlich
Aug 21, 2010·Journal of Food Science·J Wang, T Chang
May 18, 2010·Diabetes/metabolism Research and Reviews·Yu-Hong JingJan-Kan Chen
Aug 28, 2007·IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control·Steven L BaldwinJames G Miller
Oct 23, 2015·Advances in Pharmacological Sciences·Mohamed Naguib ZakariaWaleed Barakat
Apr 2, 2011·Journal of the American College of Cardiology·João L CavalcanteMouaz H Al-Mallah
Feb 20, 2015·Journal of Food Science and Technology·Chia-Chen LeeYing-Jang Lai
Aug 12, 2009·Thérapie·Alain Cohen SolalJean-Michel Tartiere
May 1, 2007·Journal of the American Society of Hypertension : JASH·Michel E SafarGérard E Plante
Sep 9, 2006·Endocrinology and Metabolism Clinics of North America·Shi Fang YanAnn Marie Schmidt
Jan 16, 2007·Current Opinion in Lipidology·Seung Hwan HanKwang Kon Koh
Jan 29, 2008·Nature Clinical Practice. Cardiovascular Medicine·Dinko Susic, Edward D Frohlich
Apr 30, 2008·Diabetes/metabolism Research and Reviews·Maya S P HuijbertsCasper G Schalkwijk
Jul 28, 2005·Current Opinion in Nephrology and Hypertension·Angel CogolludoJuan Tamargo
Sep 15, 2005·American Journal of Physiology. Renal Physiology·Jürgen M BohlenderGunter Wolf
Mar 21, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Michel E Safar, P Lacolley
Oct 25, 2007·Biochemical Society Transactions·D Susic
Nov 5, 2019·Hypertension·Carlos M FerrarioHector O Ventura
Sep 19, 2019·Clinical Journal of the American Society of Nephrology : CJASN·Camilo G SotomayorStephan J L Bakker
Aug 30, 2018·Current Vascular Pharmacology·Camilla Krizhanovskii, Anders Franco-Cereceda
Aug 11, 2019·Biochimica Et Biophysica Acta. General Subjects·Sneha B Bansode, Rajesh N Gacche
Apr 12, 2005·Advances in Chronic Kidney Disease·Mark E Williams, Katherine R Tuttle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.